Schedule 13D ownership disclosure

DIANTHUS THERAPEUTICS INC COM

Security class unavailable · CUSIP: 55910K108

Event date: 2021-04-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
26,640,361
Percent of class
4.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-22-005741
Form type
SC 13D/A
Filer
Atlas Venture Fund X, L.P.
CIK
CIK 1628098
Filed
May 05, 2022
Reporting period
Apr 13, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub